Device
QuiremSpheres
QuiremSpheres is a medical device with 4 clinical trials. Historical success rate of 66.7%.
Total Trials
4
Max Phase
—
Type
DEVICE
Molecule
—
Success Metrics
Clinical Success Rate
66.7%
Based on 2 completed trials
Completion Rate
67%(2/3)
Active Trials
0(0%)
Results Posted
0%(0 trials)
Terminated
1(25%)
Phase Distribution
Ph not_applicable
4
100%
Phase Distribution
0
Early Stage
0
Mid Stage
0
Late Stage
Phase Distribution4 total trials
N/ANon-phased studies
4(100.0%)
Highest Phase Reached
UnknownTrial Status & Enrollment
Completion Rate
66.7%
2 of 3 finished
Non-Completion Rate
33.3%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(2)
Terminated(1)
Other(1)
Detailed Status
Completed2
unknown1
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
66.7%
Most Advanced
N/A
Trials by Phase
N/A4 (100.0%)
Trials by Status
completed250%
unknown125%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
terminatednot_applicable
Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NCT05705791
completednot_applicable
Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer
NCT05191498
unknownnot_applicable
Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients
NCT06142344
completednot_applicable
Real-time Imaging of Holmium Radioembolization: a Feasibility Study
NCT04269499
Clinical Trials (4)
Showing 4 of 4 trials
NCT05705791Not Applicable
Clinical Investigation Evaluating Safety and Efficacy of Selective Intra-arterial 166Holmium Radiation Therapy in Combination With Atezolizumab and Bevacizumab for Non Resectable Hepatocellular Carcinoma
NCT05191498Not Applicable
Intratumoral Holmium Microspheres Brachytherapy for Patients With Pancreatic Cancer
NCT06142344Not Applicable
Radioembolisation and Chemotherapy in Liver Metastatic Breast Cancer Patients
NCT04269499Not Applicable
Real-time Imaging of Holmium Radioembolization: a Feasibility Study
All 4 trials loaded
Drug Details
- Intervention Type
- DEVICE
- Total Trials
- 4